Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Pfizer
Jazz Pharmaceuticals
Seagen Inc.
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
DualityBio Inc.
Daiichi Sankyo
Mayo Clinic
I-Mab Biopharma US Limited
Sotio Biotech Inc.
University of California, Irvine
Elevation Oncology
Rain Oncology Inc
Exelixis
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
pharmaand GmbH
Canadian Cancer Trials Group
Hoffmann-La Roche
OncoNano Medicine, Inc.
Northwestern University
Istituto Clinico Humanitas
Duke University
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Seagen Inc.
Cambridge University Hospitals NHS Foundation Trust
Eli Lilly and Company
Novartis
Bay Area Gynecology Oncology
Washington University School of Medicine
Sanofi
Novartis
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Amgen
Schillerhoehe Hospital
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
University of California, San Francisco
M.D. Anderson Cancer Center
Scripps Health